Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angina V: Nursing Management01:20

Angina V: Nursing Management

267
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
267
Angina IV: Management01:26

Angina IV: Management

205
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
205
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

199
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
199
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

6.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.1K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

1.3K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.3K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

1.9K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osmotic stress alters exopolysaccharide partitioning in Bacteroides fragilis.

Scientific reports·2026
Same author

Understanding the Food Waste Reduction Intentions of Consumers in Turkiye Through the Value-Attitude-Behavior Framework.

Foods (Basel, Switzerland)·2026
Same author

Microbial Dynamics of Yogurts with Different Starter Cultures Under an In Vitro Gastrointestinal System Using 16S rRNA Sequencing.

Foods (Basel, Switzerland)·2026
Same author

Nutritional quality of plant-based beverages in Türkiye: application of the updated nutri-score algorithm.

Frontiers in nutrition·2026
Same author

Development and Validation of the Athlete Food Insecurity Scale (AFIS).

Nutrients·2026
Same author

Anxiety as a mediator between preservice teachers' attitudes toward mathematics teaching and their self-efficacy beliefs.

Frontiers in psychology·2026

Related Experiment Video

Updated: Jan 5, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.2K

Nitric oxide and the CABG patient.

Tatsiana Suvorava1, Vu Thao-Vi Dao, Murat Bas

  • 1Institute of Pharmacology and Clinical Pharmacology, Heinrich Heine University, Duesseldorf, Germany.

Current Opinion in Pharmacology
|January 31, 2012
PubMed
Summary

Coronary artery bypass grafting (CABG) success is challenged by graft issues. Endothelial nitric oxide (NO) bioavailability is crucial for graft function and patency, warranting further investigation in CABG patients.

More Related Videos

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
08:35

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

3.0K
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
08:23

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds

Published on: February 16, 2022

4.7K

Related Experiment Videos

Last Updated: Jan 5, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.2K
Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
08:35

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

3.0K
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
08:23

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds

Published on: February 16, 2022

4.7K

Area of Science:

  • Cardiovascular Surgery
  • Vascular Biology
  • Endothelial Function

Background:

  • Coronary artery bypass grafting (CABG) success is limited by post-operative complications like thrombosis, de-endothelialization, intimal hyperplasia, and atherosclerosis.
  • The endothelium's role in graft patency is critical, with nitric oxide (NO) bioavailability being a key factor.

Purpose of the Study:

  • To investigate the role of endothelial nitric oxide (NO) bioavailability in the function and patency of grafts after coronary artery bypass grafting (CABG).
  • To explore the vasoprotective potential of NO in CABG patients.

Main Methods:

  • Review of existing literature on CABG complications and endothelial function.
  • Analysis of factors influencing NO bioavailability, including graft type, surgical procedure, and patient management.
  • Assessment of current data supporting the role of NO in graft patency.

Main Results:

  • Graft type, harvesting, storage, surgical approach, physical activity, and drug therapy can influence NO bioavailability.
  • While the exact impact of endothelial NO bioavailability on graft patency and clinical outcomes remains under investigation, current evidence suggests a positive role.

Conclusions:

  • Endothelial NO bioavailability is a significant factor for graft function and patency in CABG patients.
  • Further research is needed to fully elucidate the vasoprotective effects of NO and optimize its therapeutic potential in CABG patients.